 HANOVER, MD., July 12, 2022 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. Nasdaq: PCSA Processa or the Company, a clinical stage biopharmaceutical company developing drugs to improve the survival andor quality of life for patients who have unmet medical conditions announced today that Dr. David Young, its Chief Executive Officer, will present Thinking Regulatory First - Considerations for the Effective Development of Rare Disease Therapies at the World Orphan Drug Congress USA 2022 Conference on Wednesday, July 13, 2022 at 3:25 pm EDT. 